Dr. Suzanne Schindler is a clinical neurologist and neuroscientist committed to improving the diagnosis and treatment of Alzheimer disease. She completed her scientific and medical training at Washington University in St. Louis. Dr. Schindler sees patients with memory concerns and coordinates biomarker testing for the Washington University Memory Diagnostic Center. She leads the Fluid Biomarker Core for the Knight Alzheimer Disease Research Center. Her research is focused on the clinical validation of blood tests for Alzheimer disease and use of biomarker testing in clinical diagnosis.
Dr. Schindler has no financial interests in any pharmaceutical companies and has not received any direct research funding from any pharmaceutical companies. She has served on scientific advisory boards on biomarker testing and education for Eisai and Novo Nordisk and has received speaking fees for presentations on biomarker testing from Eisai, Eli Lilly, and Novo Nordisk.
